 Treatment childhood angiomatous diseases recombinant interferon heterogeneous group patients progressive invasive angiomatous diseases pulmonary hemangiomatosis angiosarcoma massive hemangioma associated consumptive coagulopathy interferon periods months patient large thoracic hemangioma cardiorespiratory failure consumptive coagulopathy months treatment patients beneficial responses regression abnormal vessels pulmonary angiogram exercise tolerance pulmonary hemangiomatosis patients corticosteroid and/or platelet transfusion requirements consumptive coagulopathy patients size number tumor nodules patient angiosarcoma angiomatous lesions Responses periods months treatment measurable progression angiomatous lesions patient receiving interferon therapeutic dose one surviving patients linear growth weight gain interferon treatment